Hi E, There’s no doubt that the biotech industry is facing tough times: shares are in freefall, investors have shut off the tap that flowed in the wake of the COVID crisis, clinical results are beginning to thin the good ideas from the bad and small companies are being forced to lay off staff. How can companies stay afloat, raise money and survive in this bear market? Join us next month at the Fierce Biotech Summit in Boston, MA on September 19-20, 2022 and hear from leading experts from the investor and biotech sides on how to stay viable and competitive in this bear market. Hear from executives who have experienced different market conditions and learned how to navigate the challenges. |
